--- title: "ENDONOVO THERAPEUTICS, INC. (ENDV) stock and investor profile" url: "https://aibio.space/companies/endonovo-therapeutics/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "ENDONOVO THERAPEUTICS, INC. (OTC: ENDV), United States. Listing facts, related biotech companies and news on aibio.space." --- ENDV ENDONOVO THERAPEUTICS, INC. OTC · United States # ENDONOVO THERAPEUTICS, INC. (ENDV) news ENDONOVO THERAPEUTICS, INC. is a public biotech or pharmaceutical company listed on OTC under the ticker ENDV, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. ## Latest ENDONOVO THERAPEUTICS, INC. news We have not published a story on ENDONOVO THERAPEUTICS, INC. yet. When there is news, it will appear here. ## ENDONOVO THERAPEUTICS, INC. at a glance - **Ticker**: ENDV - **Listing**: OTC - **Country**: United States - **Cash, Sep 30, 2023**: $0 ### Related companies - [SMITH & NEPHEW](https://aibio.space/companies/smith-nephew/) NYSE: SNN - [VITASPRING BIOMEDICAL CO. LTD.](https://aibio.space/companies/vitaspring-biomedical/) OTC: VSBC - [Nuwellis](https://aibio.space/companies/nuwellis/) NASDAQ: NUWE - [BOSTON SCIENTIFIC CORP](https://aibio.space/companies/boston-scientific/) NYSE: BSX - [ALIGN TECHNOLOGY INC](https://aibio.space/companies/align-technology/) NASDAQ: ALGN - [UL Solutions](https://aibio.space/companies/ul-solutions/) NYSE: ULS - [Beta Bionics](https://aibio.space/companies/beta-bionics/) NASDAQ: BBNX - [ENvue Medical](https://aibio.space/companies/envue-medical/) OTC: FEED ### Also on OTC - [CTT Pharmaceutical Holdings](https://aibio.space/companies/ctt-pharmaceutical/) CTTH - [QHSLab](https://aibio.space/companies/qhslab/) USAQ - [Innovation Pharmaceuticals](https://aibio.space/companies/innovation-pharmaceuticals/) IPIX - [Lifeloc Technologies](https://aibio.space/companies/lifeloc-technologies/) LCTC - [Mosaic ImmunoEngineering](https://aibio.space/companies/mosaic-immunoengineering/) CPMV - [VITASPRING BIOMEDICAL CO. LTD.](https://aibio.space/companies/vitaspring-biomedical/) VSBC ## ENDONOVO THERAPEUTICS, INC. annual financials | Line | FY2022 | FY2021 | |---|---|---| | Research and development | | [$0](https://www.sec.gov/Archives/edgar/data/1528172/000149315222009861/) | | Net income (loss) | [-$18.5 million](https://www.sec.gov/Archives/edgar/data/1528172/000149315223012553/) | [-$3.1 million](https://www.sec.gov/Archives/edgar/data/1528172/000149315223012553/) | | Cash from operations | [-$678,838](https://www.sec.gov/Archives/edgar/data/1528172/000149315223012553/) | [-$986,584](https://www.sec.gov/Archives/edgar/data/1528172/000149315223012553/) | | Cash and equivalents | [$98](https://www.sec.gov/Archives/edgar/data/1528172/000149315223046444/) | [$85,936](https://www.sec.gov/Archives/edgar/data/1528172/000149315222033118/) | Latest balance sheet, Sep 30, 2023 (10-Q): cash and equivalents $0. Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice. ## Questions about ENDONOVO THERAPEUTICS, INC. What is the ticker symbol of ENDONOVO THERAPEUTICS, INC.? ENDONOVO THERAPEUTICS, INC. trades under the ticker ENDV on OTC. Where is ENDONOVO THERAPEUTICS, INC. listed? ENDONOVO THERAPEUTICS, INC. is listed on OTC. Which country or territory is ENDONOVO THERAPEUTICS, INC. listed under? Our directory records ENDONOVO THERAPEUTICS, INC. under United States. Does aibio.space cover ENDONOVO THERAPEUTICS, INC.? aibio.space lists ENDONOVO THERAPEUTICS, INC. among 2,820 public biotech companies and publishes its news here as stories appear. Is ENDONOVO THERAPEUTICS, INC. profitable? ENDONOVO THERAPEUTICS, INC. reported a net loss of $18.5 million for the fiscal year ended Dec 31, 2022, and used $678,838 of cash in operations, per its annual report to the SEC. How much cash does ENDONOVO THERAPEUTICS, INC. have? $0 in cash at Sep 30, 2023, per its 10-Q. ## Investor discussion: ENDONOVO THERAPEUTICS, INC. Members talk about ENDONOVO THERAPEUTICS, INC. (ENDV). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open OTC:ENDV on TradingView](https://www.tradingview.com/symbols/OTC-ENDV/). ## Listing details ENDONOVO THERAPEUTICS, INC. is a public biotech or pharmaceutical company listed on OTC under the ticker ENDV, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: ENDONOVO THERAPEUTICS, INC. - **Ticker**: ENDV - **Listing**: OTC - **Country or territory**: United States Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/endonovo-therapeutics/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "ENDONOVO THERAPEUTICS, INC. (ENDV) stock and investor profile", 2026-10-31, https://aibio.space/companies/endonovo-therapeutics/